PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medtronic Ventor Technologies Ltd.

USPTO PatentsView assignee record - 34 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medtronic ranks #9,317 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 3 technology areas.

#9,317
of 49,997 US assignees by volume
Top 45%
by Innovation Score (37.0/100)
18.3
avg claims per patent
-45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9317 · Foreign Corporation #9,317 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 34 grants
  • UPPER-Q #9,317/49,997
  • PHOTO-FINISH Magarl
  • CPC-NARROW A61F · 3 areas
  • INNOV-THIN 37.0/100
  • CLAIMS-RICH 18.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -45% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Magarl, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medtronic’s 37.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Medtronic

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medtronic's Innovation Score is 37.0/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Medtronic?

Each dot is one of Medtronic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtronic’s own 18.3 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 33.934.034.03434.034.034.1 05101520 Granted patents (volume) Avg claims / patent Magarl, LLC - 34, 15.03MagarlMahindra and Mahindra Limited - 34, 10.79Mahindra and Mahi…Mainetti (UK) Ltd - 34, 1.38Mainetti (UK)Maquet Cardiopulmonary GmbH - 34, 8.06Maquet Cardiopulm…Mercury Plastics LLC - 34, 15.47Mercury PlasticsMerrimack Pharmaceuticals, Inc. - 34, 18.21Merrimack Pharmac…Messer Industries USA, Inc. - 34, 11.79Messer Industries…National University Corporation, Iwate University - 34, 10.44National Universi…Medtronic Ventor Technologies Ltd. - 34, 18.26Medtronic Ventor
Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medtronic's grants concentrate

Medtronic Ventor Technologies Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 97.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (7 grants) versus a trough of 1 in 2024. By volume, Medtronic sits between Magarl, LLC and National University Corporation, Iwate University.

Medtronic's three-year grant acceleration

Medtronic Ventor Technologies Ltd. shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Medtronic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medtronic holds 34 patents at rank #9,324, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medtronic

By rank, the assignees closest to #9,324 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Medtronic's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medtronic, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Medtronic ranks #192 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

MRI Interventions, Inc. 37 Henny Penny Corporation 37 ADAP.TV, Inc. 37 Tokiwa Corporation 37

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018201920202022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medtronic Ventor Technologies Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 8.8%
2016 7 20.6%
2017 4 11.8%
2018 2 5.9%
2019 4 11.8%
2020 3 8.8%
2022 5 14.7%
2023 2 5.9%
2024 1 2.9%
2025partial year 3 8.8%

Which technologies does Medtronic Ventor Technologies Ltd. patent most?

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medtronic Ventor Technologies Ltd.'s patent record in context - here's where to go next.

  • Medtronic Ventor Technologies Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 97.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #9,317 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medtronic Ventor Technologies Ltd. against Magarl, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.